PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for February, 2004

Please send your questions to the NCBI Help Desk.

February 27, 2004

New Entries:

608484 CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA
608491 CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1
608492 OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1
608493 OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1
608494 OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2
608495 OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 1; OR6A1
608496 OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1
608497 OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1
608498 ZONA PELLUCIDA-BINDING PROTEIN; ZPBP
608499 ZONA PELLUCIDA BINDING PROTEIN 2

Changed Entries:

118494 CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3
118495 CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4
118510 CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1
138249 GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1
155720 MELANOMA, UVEAL
164230 OBSESSIVE-COMPULSIVE DISORDER 1; OCD1
168000 PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1; PGL1
181500 SCHIZOPHRENIA; SCZD
182135 5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A
182138 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN),
219700 CYSTIC FIBROSIS; CF
600880 BUDD-CHIARI SYNDROME
601682 GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602690 SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN;
608484 CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA

February 26, 2004

New Entries:

300480 TAK1-BINDING PROTEIN 3
608486 METASTASIS SUPPRESSOR 1; MTSS1
608487 TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5
608488 SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1
608489 STROMALIN 3; STAG3
608490 SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1

Changed Entries:

132880 NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6
134797 FIBRILLIN 1; FBN1
150330 LAMIN A/C; LMNA
273300 TESTICULAR TUMORS
311770 PHOSPHATIDYLINOSITOL GLYCAN, CLASS A; PIGA
312600 RETINITIS PIGMENTOSA 2; RP2
590050 TRANSFER RNA, MITOCHONDRIAL, LEUCINE, 1; MTTL1
601398 VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB
601769 VITAMIN D RECEPTOR; VDR
601784 CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1
601833 ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1
604668 ZINC FINGER PROTEIN 264; ZNF264
606158 BSCL2 GENE; BSCL2
606191 FORMIN-BINDING PROTEIN 1; FNBP1
606524 FORMIN-BINDING PROTEIN 2; FNBP2
607444 SBDS GENE; SBDS
608486 METASTASIS SUPPRESSOR 1; MTSS1
608487 TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5
608488 SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1

February 25, 2004

New Entries:

606691 CARCINOEMBRYONIC ANTIGEN-LIKE 1; CEAL1
608483 FUSED TOES, MOUSE, HOMOLOG OF; FTS
608485 TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2

Changed Entries:

100500 ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER
100678 ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2
102642 STEROL O-ACYLTRANSFERASE 1; SOAT1
108740 ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2
182960 SPINAL MUSCULAR ATROPHY, DISTAL
200150 CHOREOACANTHOCYTOSIS; CHAC
218030 CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
269700 BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY; BSCL
270685 SPASTIC PARAPLEGIA 17; SPG17
600354 SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600726 INDIAN HEDGEHOG; IHH
600794 SPINAL MUSCULAR ATROPHY, DISTAL, TYPE V; DSMAV
600862 HIV-1 REV-BINDING PROTEIN; HRB
601311 STEROL O-ACYLTRANSFERASE 2; SOAT2
605190 TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1
605645 RESISTIN-LIKE PROTEIN, BETA; RETNLB
605978 VACUOLAR PROTEIN SORTING 13A; VPS13A
606158 BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY GENE 2; BSCL2
606438 HUNTINGTON DISEASE-LIKE 2; HDL2

February 24, 2004

New Entries:

607100 NEPHROCYSTIN; NPHP1
Clinical Synopsis for 300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES

Changed Entries:

107670 APOLIPOPROTEIN A-II; APOA2
109535 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 5; TNFRSF5
140100 HAPTOGLOBIN; HP
143890 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT
164160 LEPTIN; LEP
185640 RIBOSOMAL PROTEIN L7a; RPL7A
205100 AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
256100 NEPHRONOPHTHISIS 1; NPHP1
300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2
300085 CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300110 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F
300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
602109 MATRILIN 3; MATN3
603197 NEUROPATHY TARGET ESTERASE
603272 CONNECTOR ENHANCER OF KSR, DROSOPHILA, HOMOLOG OF
603896 LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
603945 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5
605552 ABDOMINAL OBESITY-METABOLIC SYNDROME
605572 ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2
606324 PARKINSON DISEASE, TYPE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606352 ALSIN
606598 GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
Clinical Synopsis for 300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC
Clinical Synopsis for 300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES

February 23, 2004

New Entries:

300473 NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1

Changed Entries:

107910 CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
108740 ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2
118485 CYTOCHROME P450, SUBFAMILY XIA; CYP11A
146110 HYPOGONADOTROPIC HYPOGONADISM
150330 LAMIN A/C; LMNA
164730 V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1
184757 NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1
188830 PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
300018 DOSAGE-SENSITIVE SEX REVERSAL; DSS
300097 MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1
300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC
300290 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300473 NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1
305900 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
306190 GONADOTROPIN DEFICIENCY; GTD
308800 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI; KFSD
313020 SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE; SAT
313430 SRY-BOX 3; SOX3
600617 STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR
602537 CALPAIN 5; CAPN5
603490 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4
604630 NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2
605817 RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3
606043 ZINC FINGER PROTEIN 331; ZNF331
607102 WILMS TUMOR 1 GENE; WT1
608160 SRY-BOX 9; SOX9
608441 SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1

February 20, 2004

New Entries:

300474 GLYCEROL KINASE; GK
608479 SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7
608480 SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8
608481 SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9
608482 MATRIX METALLOPROTEINASE 25; MMP25

Changed Entries:

103050 ADENYLOSUCCINASE DEFICIENCY
112500 BRACHYDACTYLY, TYPE A1; BDA1
131240 ENDOTHELIN 1; EDN1
138850 GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
139320 GNAS COMPLEX LOCUS; GNAS
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
182230 SEPTOOPTIC DYSPLASIA
187050 TEETH PRESENT AT BIRTH
300290 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300474 GLYCEROL KINASE; GK
306190 GONADOTROPIN DEFICIENCY; GTD
307030 HYPERGLYCEROLEMIA
601464 LYMPHOID NUCLEAR PROTEIN RELATED TO AF4; LAF4
601609 L-3-@HYDROXYACYL-CoA DEHYDROGENASE, SHORT CHAIN; HADHSC
601802 HOMEO BOX GENE EXPRESSED IN ES CELLS; HESX1
603423 PR DOMAIN-CONTAINING PROTEIN 1; PRDM1
603959 CLAUDIN 16; CLDN16
604980 GTPase-ACTIVATING PROTEIN, RAC, 1; RACGAP1
608232 LEUKEMIA, CHRONIC MYELOID; CML
608382 DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY A, MEMBER 3; DNAJA3

February 20, 2004

New Entries:

608477 ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3
608478 ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4

Changed Entries:

603215 N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA
603418 ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2
608467 STONIN 2
608472 BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II
608478 ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4

February 19, 2004

New Entries:

606889 ALZHEIMER DISEASE, FAMILIAL, TYPE 4; AD4
608472 BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II
608474 MYOPIA 5
608475 3-@HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH
608476 TBK1-BINDING PROTEIN 1

Changed Entries:

100800 ACHONDROPLASIA; ACH
104300 ALZHEIMER DISEASE; AD
109675 SIALYLTRANSFERASE 1; SIAT1
113900 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE I; PFHBI
118450 ALAGILLE SYNDROME; AGS
120200 COLOBOMA, OCULAR
125660 DESMIN; DES
130160 ELASTIN; ELN
144250 HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL
160700 MYOPIA 2; MYP2
163950 NOONAN SYNDROME 1; NS1
176801 PROSAPOSIN; PSAP
177850 PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL DOMINANT; PXE
182381 SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2;
187950 THROMBOCYTHEMIA, ESSENTIAL
188360 THYMOCYTE ANTIGEN CD1B; CD1B
191100 TUBEROUS SCLEROSIS; TS
207750 APOLIPOPROTEIN C-II DEFICIENCY
212750 CELIAC DISEASE; CD
218030 CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
219700 CYSTIC FIBROSIS; CF
222300 WOLFRAM SYNDROME
232300 GLYCOGEN STORAGE DISEASE II
245000 PAPILLON-LEFEVRE SYNDROME; PALS
248600 MAPLE SYRUP URINE DISEASE
254210 MYASTHENIA GRAVIS, FAMILIAL INFANTILE; FIMG
263200 POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
264800 PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL RECESSIVE; PXE
277300 SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE, 1
300352 CREATINE DEFICIENCY SYNDROME, X-LINKED
302380 CATEL-MANZKE SYNDROME
304700 MOHR-TRANEBJAERG SYNDROME; MTS
600047 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
600510 GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
600759 PRESENILIN 2; PSEN2
601057 PROGRAMMED CELL DEATH 6; PDCD6
601144 BRUGADA SYNDROME
601329 LIM DOMAIN KINASE 1; LIMK1
601679 GENERAL TRANSCRIPTION FACTOR II-I; GTF2I
602291 FORKHEAD BOX J1; FOXJ1
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
603072 AURORA KINASE A; AURKA
604970 AURORA KINASE B; AURKB
605918 SPONDIN 2; SPON2
606003 TRANSALDOLASE DEFICIENCY
606889 ALZHEIMER DISEASE, FAMILIAL, TYPE 4; AD4
607093 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
608464 VG5Q GENE
608472 BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE II

February 18, 2004

New Entries:

608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1
608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
608473 ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1

Changed Entries:

104311 PRESENILIN 1; PSEN1
107670 APOLIPOPROTEIN A-II; APOA2
107730 APOLIPOPROTEIN B; APOB
120360 MATRIX METALLOPROTEINASE 2; MMP2
121800 CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER
121820 CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE
121900 GROENOUW TYPE I CORNEAL DYSTROPHY; CDGG1
122200 CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1
123900 VILLIN 2; VIL2
133170 ERYTHROPOIETIN; EPO
138190 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
146930 INTERLEUKIN 8; IL8
151385 RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1
159440 MYELIN PROTEIN ZERO; MPZ
162200 NEUROFIBROMATOSIS, TYPE I; NF1
174763 POLYMERASE, DNA, GAMMA; POLG
176807 PROSTATE CANCER
176960 PROTEIN KINASE C, ALPHA; PRKCA
177000 PROTOPORPHYRIA, ERYTHROPOIETIC
177061 MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS
181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT; EDMD2
190196 TRANSGLUTAMINASE 2; TGM2
191160 TUMOR NECROSIS FACTOR; TNF
204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE
219000 FRASER SYNDROME
252800 ALPHA-L-IDURONIDASE; IDUA
260565 PEHO SYNDROME
300389 RETINITIS PIGMENTOSA 3; RP3
300392 WAS GENE; WAS
301000 WISKOTT-ALDRICH SYNDROME; WAS
309470 MENTAL RETARDATION, X-LINKED, SYNDROMIC 3; MRXS3
312610 RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR
314670 X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
600163 SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
600262 PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2
600409 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601395 CHEMOKINE, CC MOTIF, LIGAND 3-LIKE PROTEIN 1; CCL3L1
601536 NAVAJO BRAIN STEM SYNDROME
601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
601692 TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI
602082 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2
602544 PARKIN; PARK2
603461 CELL DIVISION CYCLE 16, S. CEREVISIAE, HOMOLOG OF; CDC16
603462 CELL DIVISION CYCLE 23; CDC23
603830 LONG QT SYNDROME 3; LQT3
603937 RETINITIS PIGMENTOSA 1 GENE; RP1
604400 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5
604597 GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1
605082 RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1
605257 ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
606692 RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
606838 APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN CONTAINING A CARD
606946 ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2
606947 ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4
606949 ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7
607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
607572 LEPROSY, SUSCEPTIBILITY TO, 2
607677 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I
607822 ALZHEIMER DISEASE, FAMILIAL, TYPE 3; AD3
608337 OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1
608427 PARKIN COREGULATED GENE; PACRG
608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1

February 18, 2004

New Entries:

608466 ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1
608467 STONIN 2
608468 CARBON CATABOLITE REPRESSION 4, S. CEREVISIAE, HOMOLOG OF; CCRN4L
608469 DEAD/H BOX 17; DDX17
Clinical Synopsis for 608390 MYOTONIA, POTASSIUM-AGGRAVATED

Changed Entries:

102582 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3
103220 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 4; SLC25A4
105800 ANEURYSM, INTRACRANIAL BERRY
109535 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 5; TNFRSF5
114107 PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC
118470 CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP
118504 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
120920 MEMBRANE COFACTOR PROTEIN; MCP
123900 VILLIN 2; VIL2
124015 CYTOCHROME P450 REDUCTASE; POR
136430 FOLATE RECEPTOR 1, ADULT; FOLR1
143100 HUNTINGTON DISEASE; HD
147670 INSULIN RECEPTOR; INSR
150330 LAMIN A/C; LMNA
150370 LAMININ RECEPTOR 1; LAMR1
153622 MACROPHAGE SCAVENGER RECEPTOR; MSR1
154040 RD RNA-BINDING PROTEIN; RDBP
158590 MUSCULAR ATROPHY, ADULT SPINAL
164011 NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1
167414 PAIRED BOX GENE 5; PAX5
167416 PAIRED BOX GENE 9; PAX9
168350 MOVED TO 168300
168600 PARKINSON DISEASE; PD
175700 GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
176670 HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
176943 FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
177020 PROTEINASE 3; PRTN3
178500 PULMONARY FIBROSIS, IDIOPATHIC
182960 SPINAL MUSCULAR ATROPHY, DISTAL
207410 ANTLEY-BIXLER SYNDROME; ABS
227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
235400 HEMOLYTIC-UREMIC SYNDROME; HUS
236200 HOMOCYSTINURIA
246900 DIHYDROLIPOAMIDE DEHYDROGENASE; DLD
248370 MANDIBULOACRAL DYSPLASIA; MAD
248610 DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
248611 BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
259500 OSTEOGENIC SARCOMA
268210 RHABDOMYOSARCOMA 1; RMS1
300150 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER A5; SLC25A5
300307 T-BOX 22; TBX22
303400 CLEFT PALATE, X-LINKED; CPX
600264 ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B
600502 IMMUNOGLOBULIN MU BINDING PROTEIN 2; IGHMBP2
600513 EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1
600794 SPINAL MUSCULAR ATROPHY, DISTAL, TYPE V; DSMAV
600859 JTV1 GENE
601205 SINE OCULIS HOMEO BOX, DROSOPHILA, HOMOLOG OF, 1; SIX1
601284 ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRL1
601487 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601637 CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1
602291 FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 13; FKHL13
602544 PARKIN; PARK2
602783 SPASTIC PARAPLEGIA 7 GENE; SPG7
603013 SCHIZOPHRENIA 6; SCZD6
603215 N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA
603700 ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP
604277 SPG4 GENE; SPG4
604320 SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1; SMARD1
605357 STONED B/TFIIA-ALPHA/BETA-LIKE FACTOR
606002 SPINOCEREBELLAR ATAXIA, RECESSIVE, NON-FRIEDREICH TYPE 1
606410 ANTHRAX TOXIN RECEPTOR 1; ANTXR1
606679 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5;
606761 MALONYL-CoA DECARBOXYLASE; MLYCD
606843 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3
607991 SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3
608465 SENATAXIN
Clinical Synopsis for 160500 MYOPATHY, DISTAL 1; MPD1
Clinical Synopsis for 168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC
Clinical Synopsis for 168350 MOVED TO 168300
Clinical Synopsis for 170400 HYPOKALEMIC PERIODIC PARALYSIS; HOKPP
Clinical Synopsis for 170500 HYPERKALEMIC PERIODIC PARALYSIS; HYPP
Clinical Synopsis for 246900 DIHYDROLIPOAMIDE DEHYDROGENASE; DLD
Clinical Synopsis for 248610 DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
Clinical Synopsis for 248611 BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB

February 13, 2004

New Entries:

606504 MLN51 GENE
606692 RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
608464 VG5Q GENE
608465 SENATAXIN

Changed Entries:

123900 VILLIN 2; VIL2
125220 DEFENSIN, ALPHA, 1; DEFA1
139320 GNAS COMPLEX LOCUS; GNAS
149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME
179410 RADIXIN; RDX
191390 ULCERATIVE COLITIS, SUSCEPTIBILITY TO
228600 FIBROMATOSIS, JUVENILE HYALINE
236490 HYALINOSIS, INFANTILE SYSTEMIC
268800 SANDHOFF DISEASE
309845 MOESIN; MSN
600246 ELK4, ETS-DOMAIN PROTEIN; ELK4
600354 SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600702 SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600716 PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8; PTPN8
601373 CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5
601693 UNCOUPLING PROTEIN 2; UCP2
601739 MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1
602695 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
604378 BECLIN 1; BECN1
604522 DEFENSIN, ALPHA, 3; DEFA3
604933 MutY, E. COLI, HOMOLOG OF; MUTYH
604986 BRCA1-ASSOCIATED PROTEIN; BRAP
606002 SPINOCEREBELLAR ATAXIA, RECESSIVE, NON-FRIEDREICH TYPE 1
606692 RING FINGER- AND WD REPEAT DOMAIN-CONTAINING PROTEIN 1; RFWD1
608041 ANTHRAX TOXIN RECEPTOR 2; ANTXR2
608465 SENATAXIN
Clinical Synopsis for 149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME

February 12, 2004

New Entries:

607234 MAS-RELATED GENE MRGG
608463 APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF

Changed Entries:

120970 CONE-ROD DYSTROPHY 2; CORD2
123590 CRYSTALLIN, ALPHA-B; CRYAB
157660 MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP
171060 ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4
188400 DIGEORGE SYNDROME; DGS
192340 ARGININE VASOPRESSIN; AVP
192430 VELOCARDIOFACIAL SYNDROME
193300 VON HIPPEL-LINDAU SYNDROME; VHL
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
208050 ARTERIAL TORTUOSITY
217095 CONOTRUNCAL HEART MALFORMATIONS; CTHM
219080 CUSHING DISEASE, ADRENAL
600156 HIRSCHSPRUNG DISEASE MODIFIER 1
600803 CHOLELITHIASIS
601081 ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2
601419 DESMIN-RELATED MYOPATHY
601530 SEQUESTOSOME 1; SQSTM1
601556 ATAXIN 1; ATX1
601816 BILIRUBIN, ELEVATED CONCENTRATIONS OF, IN SERUM
601914 PROLINE ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP
602054 T-BOX 1; TBX1
603150 ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, DELTA SUBUNIT;
604392 ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1
607042 CLN3 GENE; CLN3
607379 NEUROFIBROMIN 2; NF2
607981 NEDD8 ULTIMATE BUSTER 1
608441 SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1

February 11, 2004

New Entries:

300477 FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A
300478 FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B
300479 FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C
608461 COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1
608462 HIRSCHSPRUNG DISEASE MODIFIER 2

Changed Entries:

104300 ALZHEIMER DISEASE; AD
108500 EPISODIC ATAXIA, TYPE 2; EA2
126375 DNA METHYLTRANSFERASE 1; DNMT1
126453 DOPAMINE RECEPTOR D5; DRD5
142623 HIRSCHSPRUNG DISEASE
143000 HORNER SYNDROME, CONGENITAL
147720 INTERLEUKIN 1-BETA; IL1B
163905 HIGH MOBILITY GROUP BOX 1; HMGB1
185250 MATRIX METALLOPROTEINASE 3; MMP3
185620 SURFEIT 1; SURF1
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
245200 KRABBE DISEASE
256000 LEIGH SYNDROME; LS
272120 SUDDEN INFANT DEATH SYNDROME
590060 TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK
600214 ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER
600409 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601995 TENASCIN-R; TNR
603099 1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1
604759 SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3
605996 DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z
606798 BLEPHAROSPASM, BENIGN ESSENTIAL
606875 HIRSCHSPRUNG DISEASE, SHORT-SEGMENT, 3
607136 SPINOCEREBELLAR ATAXIA 17; SCA17
607139 FANCONI ANEMIA COMPLEMENTATION GROUP A GENE; FANCA

February 10, 2004

New Entries:

608423 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
608456 COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE
608457 CHROMOBOX HOMOLOG 7; CBX7
608458 NEUROCHONDRIN
608459 CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3
608460 ZINC FINGER PROTEIN 276; ZFP276

Changed Entries:

106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
120620 COMPLEMENT COMPONENT RECEPTOR 1; CR1
123810 cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
142410 TRANSCRIPTION FACTOR 1; TCF1
144650 HYPERLIPOPROTEINEMIA, TYPE V
166200 OSTEOGENESIS IMPERFECTA, TYPE I
166220 OSTEOGENESIS IMPERFECTA, TYPE IV
176980 PROTEIN KINASE C, GAMMA; PRKCG
180069 RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65
189965 CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB
190196 TRANSGLUTAMINASE 2; TGM2
191830 UROGENITAL ADYSPLASIA, HEREDITARY
194350 WT LIMB-BLOOD SYNDROME
207800 ARGININEMIA
210000 BEHR SYNDROME
259420 OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
300259 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
300292 FORKHEAD BOX P3; FOXP3
304790 IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED;
309550 FRAGILE SITE MENTAL RETARDATION 1 GENE; FMR1
600234 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2, MITOCHONDRIAL; HMGCS2
601545 PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT;
601754 UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L
602404 PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY; PARK3
603501 POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG
604834 TANK-BINDING KINASE 1; TBK1
604933 MutY, E. COLI, HOMOLOG OF; MUTYH
605189 DICKKOPF, XENOPUS, HOMOLOG OF, 1; DKK1
605361 SPINOCEREBELLAR ATAXIA 14; SCA14
606232 CHROMOSOME 22q13.3 DELETION SYNDROME
606896 DYSLEXIA, SPECIFIC, 5; DYX5
607432 LISSENCEPHALY I; LIS1
607949 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY, 1
608451 ETHE1 GENE; ETHE1
608456 COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE
Clinical Synopsis for 119530 OROFACIAL CLEFT 1; OFC1

February 9, 2004

New Entries:

608451 ETHYLMALONIC ENCEPHALOPATHY GENE 1; ETHE1
608453 CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC
608454 KNOBLOCH SYNDROME, TYPE II

Changed Entries:

106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
120328 COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1
123970 CYTOCHROME C
126453 DOPAMINE RECEPTOR D5; DRD5
143465 ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
147265 INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1
151443 LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR
165360 CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG;
176805 PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
209950 ATYPICAL MYCOBACTERIOSIS, FAMILIAL
212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
224500 DYSTONIA MUSCULORUM DEFORMANS 2; DYT2
250100 METACHROMATIC LEUKODYSTROPHY
254780 MYOCLONIC EPILEPSY OF LAFORA
259420 OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
267750 KNOBLOCH SYNDROME; KNO
300335 ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2
302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED, 1; CMTX1
600262 PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2
600985 TENASCIN-XB; TNXB
601253 CAVEOLIN 3; CAV3
601559 STUVE-WIEDEMANN SYNDROME
601773 PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN
602006 MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2
602473 ENCEPHALOPATHY, ETHYLMALONIC
604491 CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB
604710 LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4
604759 SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3
605312 BONE MORPHOGENETIC PROTEIN, PLACENTAL
607585 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
608118 ZINC IN BREAST MILK, REDUCED
608452 PLATELET-DERIVED GROWTH FACTOR C; PDGFC
Clinical Synopsis for 184260 SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
Clinical Synopsis for 234250 HALL-RIGGS MENTAL RETARDATION SYNDROME
Clinical Synopsis for 603546 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS

February 6, 2004

New Entries:

608443 MENTAL RETARDATION, NONSYNDROMIC, AUTOSOMAL RECESSIVE, 3
608452 PLATELET-DERIVED GROWTH FACTOR C; PDGFC
Clinical Synopsis for 602557 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE
Clinical Synopsis for 603005 3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
Clinical Synopsis for 603546 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS

Changed Entries:

101000 NEUROFIBROMATOSIS, TYPE II; NF2
113705 BREAST CANCER 1 GENE; BRCA1
119530 OROFACIAL CLEFT 1; OFC1
120960 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II
124080 CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125660 DESMIN; DES
139340 GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE
142983 MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 1; MSX1
164761 REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
176000 PORPHYRIA, ACUTE INTERMITTENT
176807 PROSTATE CANCER
185300 STURGE-WEBER SYNDROME
249500 MENTAL RETARDATION, NONSYNDROMIC, AUTOSOMAL RECESSIVE
256550 NEURAMINIDASE DEFICIENCY
258480 OPSISMODYSPLASIA
261000 PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR
276000 PROTEASE, SERINE, 1; PRSS1
600131 EPILEPSY, CHILDHOOD ABSENCE, 1; ECA1
600185 BREAST CANCER 2 GENE; BRCA2
600276 NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3
600409 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
600669 EPILEPSY, IDIOPATHIC GENERALIZED; IGE
601487 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601530 SEQUESTOSOME 1; SQSTM1
601564 PROTEASE, SERINE, 2; PRSS2
602006 MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2
602109 MATRILIN 3; MATN3
603005 3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
603363 CGG-BINDING PROTEIN 1; CGGBP1
603546 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS
604134 A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1
604840 FK506-BINDING PROTEIN 8; FKBP8
605078 TAR DNA-BINDING PROTEIN; TARDBP
605238 HISTAMINE N-METHYLTRANSFERASE; HNMT
605833 BONE MINERAL DENSITY VARIATION 2
606157 PANTOTHENATE KINASE 2; PANK2
606397 USH3A GENE; USH3A
606530 CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1
606800 GLUCOSIDASE, ALPHA, ACID; GAA
606904 EPILEPSY, JUVENILE MYOCLONIC; JME
607102 WILMS TUMOR 1 GENE; WT1
607236 HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,
607566 EPM2A GENE; EPM2A
607631 EPILEPSY, JUVENILE ABSENCE; JAE
608272 NEURAMINIDASE 1; NEU1
Clinical Synopsis for 108500 EPISODIC ATAXIA, TYPE 2; EA2
Clinical Synopsis for 183849 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS
Clinical Synopsis for 184260 SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
Clinical Synopsis for 603005 3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2

February 5, 2004

New Entries:

300476 CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
608444 MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 5; MLL5
608445 SPEECH-SOUND DISORDER
608446 MYOCARDIAL INFARCTION, PREMATURE, SUSCEPTIBILITY TO
608447 CAROTID INTIMAL MEDIAL THICKNESS
608448 INFLAMMATORY BOWEL DISEASE 9; IBD9
608449 POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2
608450 B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE

Changed Entries:

104300 ALZHEIMER DISEASE; AD
113505 BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
114090 CALPASTATIN; CAST
119580 BLEPHAROCHEILODONTIC SYNDROME
124080 CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125220 DEFENSIN, ALPHA, 1; DEFA1
134660 GLUTATHIONE S-TRANSFERASE, PI; GSTP1
136425 FOLATE RECEPTOR 2, FETAL; FOLR2
138350 GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1
173900 POLYCYSTIC KIDNEYS
173910 POLYCYSTIC KIDNEY DISEASE 2; PKD2
186790 CD3 ANTIGEN, DELTA SUBUNIT; CD3D
193300 VON HIPPEL-LINDAU SYNDROME; VHL
267300 RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
300029 RETINITIS PIGMENTOSA 15; RP15
300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2
300085 CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300095 SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER
300476 CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
304020 CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
310200 MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
516060 ATP SYNTHASE 6; MTATP6
600666 POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3
600890 HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE,
601040 SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1
601212 PROTEIN-TYROSINE KINASE 2, BETA; PTK2B
601402 MYELOID LEUKEMIA FACTOR 1; MLF1
602096 ALZHEIMER DISEASE, FAMILIAL, TYPE 5
602548 OPIOID RECEPTOR-LIKE 1; OPRL1
602601 LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1
602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR
603590 ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE
603684 LIPASE, ENDOTHELIAL; LIPG
604522 DEFENSIN, ALPHA, 3; DEFA3
605239 ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4
605286 CALPAIN 10; CAPN10
606896 DYSLEXIA, SPECIFIC, 5; DYX5
607929 CHROMOSOME 7 OPEN READING FRAME 22; C7ORF22
608271 MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1
608410 OBESITY, SUSCEPTIBILITY TO, ON CHROMOSOME 4

February 4, 2004

New Entries:

608441 SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1
608442 SYNAPTIC NUCLEAR ENVELOPE PROTEIN 2; SYNE2

Changed Entries:

107741 APOLIPOPROTEIN E; APOE
120700 COMPLEMENT COMPONENT 3; C3
125853 DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
133780 EXUDATIVE VITREORETINOPATHY, FAMILIAL; EVR
155240 THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A
168461 CYCLIN D1; CCND1
182284 CHEMOKINE, CC MOTIF, LIGAND 4; CCL4
185300 STURGE-WEBER SYNDROME
218030 CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY
227650 FANCONI ANEMIA; FA
261600 PHENYLKETONURIA
300121 DOUBLECORTIN; DCX
300156 CANCER/TESTIS ANTIGEN 1; CTAG1
312170 PYRUVATE DEHYDROGENASE COMPLEX, E1-ALPHA POLYPEPTIDE 1; PDHA1
600890 HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE,
602192 A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10
602851 MONOGENIC AUDIOGENIC SEIZURE SUSCEPTIBILITY 1, MOUSE, HOMOLOG OF;
603460 CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1
603782 CHEMOKINE, CC MOTIF, LIGAND 4-LIKE; CCL4L
603969 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B
604087 CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1
605427 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4;
605441 ADIPOSE MOST ABUNDANT GENE TRANSCRIPT 1
605472 USHER SYNDROME, TYPE IIC; USH2C
605646 SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
605820 NONAKA MYOPATHY; NM
607278 OSTEOFIBROUS DYSPLASIA

February 3, 2004

New Entries:

300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
300472 CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,
300475 CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME
608406 VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND
608440 LACTAMASE, BETA; LACTB
Clinical Synopsis for 608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM

Changed Entries:

111680 RHESUS BLOOD GROUP, D ANTIGEN; RHD
113705 BREAST CANCER 1 GENE; BRCA1
122470 CORNELIA DE LANGE SYNDROME 1; CDL1
123810 cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1
125420 DENTIN DYSPLASIA, TYPE II
125485 DENTIN SIALOPHOSPHOPROTEIN; DSPP
136535 FORMIN; FMN
140300 HASHIMOTO THYROIDITIS
142669 HIP DYSPLASIA, BEUKES TYPE
143100 HUNTINGTON DISEASE; HD
165720 OSTEOARTHRITIS
170261 TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX,
191170 TUMOR PROTEIN p53; TP53
275000 GRAVES DISEASE
300104 GDP DISSOCIATION INHIBITOR 1; GDI1
300139 IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1
300371 ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1
300398 B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31
300475 CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME
306400 GRANULOMATOUS DISEASE, CHRONIC; CGD
600527 EPHRIN B2; EFNB2
600618 ETS VARIANT GENE 6; ETV6
600985 TENASCIN-XB; TNXB
601040 SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1
602260 PERIOD, DROSOPHILA, HOMOLOG OF; PER1
602297 EPHRIN B3; EFNB3
604517 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1; PPARGC1
605646 SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606512 PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1
607095 ANAUXETIC DYSPLASIA
607139 FANCONI ANEMIA COMPLEMENTATION GROUP A GENE; FANCA
607379 NEUROFIBROMIN 2; NF2
607697 SET-BINDING FACTOR 2; SBF2
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
608440 LACTAMASE, BETA; LACTB
Clinical Synopsis for 208230 ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC
Clinical Synopsis for 234250 HALL-RIGGS MENTAL RETARDATION SYNDROME
Clinical Synopsis for 277950 WINCHESTER DISEASE

February 2, 2004

New Entries:

608438 TOUSLED-LIKE KINASE 1; TLK1
608439 TOUSLED-LIKE KINASE 2; TLK2

Changed Entries:

127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT
139396 GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3
139397 GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3
141900 HEMOGLOBIN--BETA LOCUS; HBB
142763 H2A HISTONE FAMILY, MEMBER Z; H2AFZ
151623 LI-FRAUMENI SYNDROME; LFS
160900 DYSTROPHIA MYOTONICA 1
176801 PROSAPOSIN; PSAP
180385 LIM DOMAIN ONLY 2; LMO2
182284 CHEMOKINE, CC MOTIF, LIGAND 4; CCL4
186790 CD3 ANTIGEN, DELTA SUBUNIT; CD3D
188370 THYMOCYTE ANTIGEN CD1A; CD1A
188410 THYMOCYTE ANTIGEN CD1D; CD1D
192132 ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM
208500 ASPHYXIATING THORACIC DYSTROPHY; ATD
227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
259730 OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS
267300 RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
300400 SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
308380 INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
600418 AMPHIPHYSIN; AMPH
601828 NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
602322 TELOMERASE RNA COMPONENT; TERC
602384 PHOSPHOLIPASE D2; PLD2
603782 CHEMOKINE, CC MOTIF, LIGAND 4-LIKE; CCL4L
603902 BETA THALASSEMIA, DOMINANT INCLUSION BODY TYPE
605377 DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
608074 PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP
608148 SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH